During the past decade, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" #1 sponsor was "Korea Cancer Center Hospital" with 11 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "BeiGene" with 1 trials sponsored, "Gangnam Severance Hospital" with 1 trials sponsored and "Hallym University Medical Center" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" #1 collaborator was "Dongnam Institute of Radiological & Medical Sciences" with 3 trials as a collaborator, "Incheon St.Mary's Hospital" with 3 trials as a collaborator, "Inha University Hospital" with 3 trials as a collaborator, "Seoul National University Hospital" with 3 trials as a collaborator and "Asan Medical Center" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" are "Breast Cancer" (5 trials), "Hepatocellular Carcinoma" (4 trials), "Cervical Cancer" (3 trials), "CERVICAL NEOPLASMS" (1 trials) and "Carcinoma, Non-Small Cell Lung" (1 trials). Many other conditions were trialed in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" in a lesser frequency.

Most popular intervention types in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" are "Drug" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "131I-rituximab" (3 trials), "Atezolizumab" (2 trials), "Stereotactic ablative radiotherapy" (2 trials), "tri-weekly cisplatin" (2 trials) and "CONCURRENT CHEMORADIATION (CISPLATIN)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences" are 14 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences has several departments that took part in Clinical trials: "Korea Cancer Center Hospital" - 2 trials